Similar articles

• [Small-dose cytarabine (Ara-C) in the treatment of myelodysplastic syndrome].

  Dan K, Ogata K, Gomi S, Ohki I, Kuwabara T, Horikoshi H, Nomura T. Dan K, et al. Rinsho Ketsueki. 1984 Oct;25(10):1600-5. Rinsho Ketsueki. 1984. PMID: 6596446 Japanese. No abstract available.
• Clinical effect of low dose ara-C in twenty patients with acute nonlymphocytic leukemia, atypical leukemia, and refractory anemia with excess of blasts.

  Izumi Y, Sawada H, Okazaki T, Mochizuki T, Ishikura H, Tashima M, Yamagishi M, Uchino H, Usui T, Akasaka S, et al. Izumi Y, et al. Nihon Ketsueki Gakkai Zasshi. 1986 Feb;49(1):93-100. Nihon Ketsueki Gakkai Zasshi. 1986. PMID: 3705895 No abstract available.
• [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].

  Brodzki LM. Brodzki LM. Acta Haematol Pol. 1985 Jan-Jun;16(1-2):85-9. Acta Haematol Pol. 1985. PMID: 3914171 Review. Polish. No abstract available.
• Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.

  Satou Y, Kubota T, Yonekura S, Noguchi K, Oobayashi Y, Nagao T, Arimori S. Satou Y, et al. Tokai J Exp Clin Med. 1986 Oct;11(4):249-54. Tokai J Exp Clin Med. 1986. PMID: 3617109
• [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia].

  Yamato H, Yamada K, Koike T, Yoshida M, Tsunogake S, Aoyagi M, Nakamura Y, Watanabe K, Saito K, Enokihara H, et al. Yamato H, et al. Rinsho Ketsueki. 1995 Feb;36(2):128-33. Rinsho Ketsueki. 1995. PMID: 7536277 Review. Japanese.